Key facts
- It has raised $4.7M; the latest was Accelerator/Incubator ($10K) in Aug 2024.
- Notable investors include MIT Solve, Centre for Cellular And Molecular Platforms, Mount Judi Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for InnAccel Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for InnAccel Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InnAccel Technologies
Developer of novel medical devices designed to address critical unmet clinical needs in India and global markets. The company's devices use bio-design methods for creating technology products for the clinical environment by identifying diseases that affect Indians, enabling the medical community to get access to innovative and affordable medical devices.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2012
- Employees
- 50
- Website
- innaccel.com/
- Ownership
- Privately Held (backing)
InnAccel Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InnAccel Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InnAccel Technologies in its N-PORT filings yet. We sweep new filings monthly.